We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
How to use a before-and-after study to evaluate your digital health product.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
How to use a risk-based approach to carry out compulsory risk assessments of your business.
As part of Dstl's commitment to improving access to technologies, we're making some of our intellectual property (IP) available for free.
How to use an interrupted time series to evaluate your digital health product.
The UK government's design principles and examples of how they've been used.
Information to assist with the laboratory diagnosis of Lyme disease and requirements for sample submission.
Helping public health practitioners conducting evaluations – developing a logic model to represent how your intervention works.
Guide for overseas investors on how to access NHS procurement channels.
An overview of the work the IPO is undertaking in relation to Standard Essential Patents.
Essential information for British nationals residing in Costa Rica, covering topics like driving, employment, the health system and schools.
The final report recommends the introduction of a small suite of simple savings and protection insurance products. HM Treasury has reviewed progress made one year on from the final report.
Check what processes are considered as insufficient production under the Trade and Cooperation Agreement.
How investigators and sponsors should manage clinical trials during COVID-19
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
How to use a cost utility analysis to evaluate your digital health product.
This guide provides information about being arrested in Turkey and what conditions are like in prison there.
Get help to classify ceramic articles for import and export.
How to use a randomised controlled trial to evaluate your digital health product.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).